Results 181 to 190 of about 817,567 (359)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Barriers and facilitators of COVID-19 vaccination among drug users: a qualitative analysis for future crisis management. [PDF]

BMC Infect Dis
Karimi SE, Ahmadi S, SoleimanvandiAzar N, Rampisheh Z, Nojomi M, Sepahvand E, Tavangar F, Tehrani-Banihashemi SA, Tayefi B, Higgs P.   +9 more
europepmc   +1 more source

Recurrent Bioprosthetic Valve Serratia marcescens Endocarditis in Intravenous Drug Users. [PDF]

Am J Case Rep, 2023
Sadaqa D, Daoud A, Zeid F, Alsaid HM.
europepmc   +1 more source

Syringe vending machines for injection drug users: an experiment in Marseille, France.

, 1999
Yolande Obadia, Isabelle Feroni, V. Perrin, David Vlahov, J.P. Moatti   +4 more
openalex   +2 more sources

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Yeast fungaemia among injection drug users in France (2012-2022): a cross-sectional observational study. [PDF]

Lancet Reg Health Eur
Paccoud O, Lortholary O, Imbert S, Letscher-Bru V, Boukris-Sitbon K, Obadia T, Dalle F, Hasseine L, Morio F, Huguenin A, Poirier P, Favennec L, Bonhomme J, Alanio A, Lanternier F, Desnos-Ollivier M, French Mycoses Study Group.   +16 more
europepmc   +1 more source

Challenges Faced and Coping Strategies Adopted by Injecting Drug Users during COVID-19 Lockdown-A Qualitative Study. [PDF]

Indian J Community Med, 2023
Vashisht S, Jha S, Kant S, Thakur N, Rai S.   +4 more
europepmc   +1 more source

Strict Syringe Laws in Rhode Island Are Associated With High Rates of Reusing Syringes and HIV Risks Among Injection Drug Users

, 1998
Josiah D. Rich, Brian P. Dickinson, Kai-Lih Liu, Patricia Case, Bill M. Jesdale, Rose Marie Ingegneri, Patricia A. Nolan   +6 more
openalex   +1 more source

Cocaine Excretion in the Semen of Drug Users [PDF]

, 1996
Edward J. Cone, Kenichi Kato, Mary J. Hillsgrove   +2 more
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source